- Home
- / ChemoMetec
ChemoMetec
Stock Price
KR410.8
2024-10-29
Market Capitalization
KR7.1 B
2024-10-29
Revenue
KR407.4 M
FY, 2024
ChemoMetec Summary
Company Summary
- Overview
- ChemoMetec develops analytical instruments and techniques in the field of cell analysis. The Company offers its solutions for cell therapeutic, stem cell research, cancer cell research, cell toxicology, bioprocessing, cell biology research, sperm cell counting, yeast cell counting, and somatic cell counting applications.
- Type
- Public
- Status
- Active
- Founded
- 1997
- HQ
- Lillerød, DK | view all locations
- Website
- https://chemometec.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Niels Thestrup, Chairman of the Board
Martin Glensbjerg, Vice Chairman of the Board
Peter Reich, Board Member
LocationsView all
4 locations detected
Lillerød HQ
Denmark
Gydevang 43
Bohemia, NY
United States
3920 Veterans Memorial Hwy #3
Beausoleil, Provence-Alpes-Côte d'Azur
France
1752 D6007
Kaiserslautern, RP
Germany
Europaallee 10
ChemoMetec Financials
Summary Financials
- Revenue (FY, 2024)
- kr407.4M
- Gross profit (FY, 2024)
- kr339.8M
- Net income (FY, 2024)
- kr136.3M
- Cash (FY, 2024)
- kr296.1M
- EBIT (FY, 2024)
- kr169.0M
- Enterprise value
- $6.9B